Literature DB >> 9509494

Cocaine tolerance: behavioral, cardiovascular, and neuroendocrine function in men.

J H Mendelson1, M Sholar, N K Mello, S K Teoh, J W Sholar.   

Abstract

Cocaine tolerance was assessed by comparing the acute effects of cocaine in drug-abstinent men who reported occasional cocaine use (n = 6) and in men who met DSM-III-R diagnostic criteria for dependence on both cocaine and opiates (n = 6). Peak plasma cocaine levels were equivalent in the two groups, and pharmacokinetic analyses revealed no significant differences in cocaine levels at any time. Cocaine induced a significantly greater increase in ACTH in the occasional cocaine users than in the cocaine dependent men (p < .01). Heart rate and systolic and diastolic blood pressure increases after cocaine were also significantly greater in the occasional cocaine users than in the cocaine-dependent men (p < .05). These neuroendocrine and physiologic differences were paralleled by significantly greater subjective reports of "high" and "euphoria" by the occasional cocaine users (p < .03 to .0001). These data are consistent with the conclusion that tolerance to cocaine's physiologic, neuroendocrine, and subjective effects may occur as a function of chronic use.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9509494     DOI: 10.1016/S0893-133X(97)00146-2

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  31 in total

Review 1.  Effects of cocaine on the hypothalamic-pituitary-adrenal axis.

Authors:  L Manetti; F Cavagnini; E Martino; A Ambrogio
Journal:  J Endocrinol Invest       Date:  2014-05-23       Impact factor: 4.256

2.  Cocaine-mediated supersensitivity of 5-HT2A receptors in hypothalamic paraventricular nucleus is a withdrawal-induced phenomenon.

Authors:  G A Carrasco; L D Van de Kar; N R Sullivan; M Landry; F Garcia; N A Muma; G Battaglia
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

3.  Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.

Authors:  Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

4.  The subjective effects of cocaine: relationship to years of cocaine use and current age.

Authors:  Raj K Kalapatapu; Gillinder Bedi; Margaret Haney; Suzette M Evans; Eric Rubin; Richard W Foltin
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-19       Impact factor: 3.829

5.  Activation of physiological stress responses by a natural reward: Novel vs. repeated sucrose intake.

Authors:  Ann E Egan; Yvonne M Ulrich-Lai
Journal:  Physiol Behav       Date:  2015-03-05

6.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

Review 7.  Chronic stress, drug use, and vulnerability to addiction.

Authors:  Rajita Sinha
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

8.  Temporal pattern of cocaine intake determines tolerance vs sensitization of cocaine effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Benjamin A Zimmer; David C S Roberts; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2013-05-30       Impact factor: 7.853

9.  Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory.

Authors:  Sharon L Walsh; Eric C Donny; Paul A Nuzzo; Annie Umbricht; George E Bigelow
Journal:  Drug Alcohol Depend       Date:  2009-08-29       Impact factor: 4.492

Review 10.  Stress, alcohol and drug interaction: an update of human research.

Authors:  Magdalena Uhart; Gary S Wand
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.